Genomic, Transcriptomic, and Proteomic Diagnosis of Liver Diseases
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 274
Special Issue Editor
2. Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan
Interests: hepatitis C virus; hepatitis B virus; hepatic fibrosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic liver disease (CLD) is a global health problem that leads to progressive liver dysfunction. A significant proportion of individuals with CLD may have cirrhosis, hepatic decompensation, and hepatocellular carcinoma (HCC). With more severe hepatic dysfunction, various extrahepatic manifestations may also present that further compromise the health-related outcomes. CLD caused 1.32 million deaths and ranked the 11th leading cause of death worldwide.
Traditionally, viral hepatitis has been the leading cause of CLD. However, advances in public health strategies, including universal precaution, hygiene management, vaccination, and antiviral agents, have tremendously changed the disease features. Recently, metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as the vital etiology of CLD. Furthermore, drug-induced liver injury (DILI), immune-mediated liver injury, and genetic-associated liver diseases continue to play an essential role in CLD that cannot be overlooked.
Based on the rapid development of diagnostic skills for genomics, transcriptomics, and proteomics, state-of-the-art knowledge to help physicians manage patients with CLD. This Special Issue in the journal Diagnostics will focus on articles covering various genomic, transcriptomic, and proteomic diagnoses and management for CLD.
I am pleased to invite submissions of high-quality research-based or review papers related to the topics to create a timely and highly relevant collection of articles addressing this pertinent medical problem.
Dr. Chenhua Liu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
